SELLAS Life Sciences Group, Inc.SLSNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank71
Studio
Year-over-Year Change

Free cash flow yield

Latest
-6.91%
↑ 93% vs avg
Percentile
P71
Within normal range
Streak
2 yr
Consecutive growthElevated
Average
-96.61%
Historical baseline
PeriodValueYoY Change
2025-6.91%+87.6%
2024-55.62%+55.6%
2023-125.36%-102.7%
2022-61.85%-103.5%
2021-30.39%-34.6%
2020-22.58%+90.3%
2019-232.33%+17.8%
2018-282.67%-351.4%
2017-62.62%+27.0%
2016-85.76%-